PMID- 38511546 OWN - NLM STAT- Publisher LR - 20240325 IS - 1941-9260 (Electronic) IS - 0032-5481 (Linking) DP - 2024 Mar 25 TI - Association between serum ferritin and bone turnover marker levels in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease. PG - 1-10 LID - 10.1080/00325481.2024.2333718 [doi] AB - OBJECTIVE: To investigate the correlation between serum ferritin (SF) and bone turnover markers in type 2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease (NAFLD). METHODS: Seven hundred and forty-two people with T2DM were selected. Serum bone turnover markers: osteocalcin (OC), type I procollagen N-terminal peptide (PINP), beta-I type collagen carboxy-terminal peptide (beta-CTx), and 25-hydroxyvitamin D3 (25-[OH]-D) levels were detected. High SF (HF) was defined as the indicated SF levels above 400 ng/mL in males and more than 150 ng/mL in females. Patients were divided into four groups: T2DM+normal SF (non-HF); T2DM+high SF (HF); T2DM+NAFLD+non-HF; andT2DM+NAFLD+HF. Relationships between SF and bone turnover markers were analyzed. RESULTS: Compared with the T2DM+non-HF group, beta-CTx levels were higher in the T2DM+HFgroup. Compared with the T2DM+NAFLD+non-HF group, beta-CTx levels were increased and 25-(OH)-D levels decreased in the T2DM+NAFLD+HF group (all p < 0.05). SF was positively correlated with beta-CTx [beta = 0.074; 95% CI (0.003, 0.205)] and negatively correlated with 25-(OH)-D [beta=-0.108; 95%CI (-0.006, -0.001)]. Compared with the T2DM+non-HF group, an independent positive correlation was found between beta-CTx and SF in the T2DM+NAFLD+HF group [OR = 1.002; 95% CI (1.001, 1.004)]. Among males, SF was positively correlatedwith beta-CTx [beta = 0.114; 95% CI (0.031, 0.266)]. SF was negatively correlated with 25-(OH)-D levels in both male and female patients [beta=-0.124; 95% CI (0.007,0.001) and beta=-0.168; 95% CI (-0.012, -0.002)]. Among those >50 years of age and postmenopausal females, SF was negatively correlated with 25-(OH)-D levels [beta=-0.117; 95% CI (-0.007, -0.001) and beta=-0.003; 95% CI (-0.013, -0.003)]. CONCLUSION: SF level was positively correlated with beta-CTx in T2DM patients with NAFLD, which may promote bone resorption and increase the risk of bone loss. FAU - Chen, Chongyang AU - Chen C AUID- ORCID: 0000-0002-3370-5408 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Zhao, Yangting AU - Zhao Y AUID- ORCID: 0009-0004-8267-5999 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Lv, Xiaoyu AU - Lv X AUID- ORCID: 0000-0003-1491-6506 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Li, Kai AU - Li K AUID- ORCID: 0009-0004-1744-676X AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Wang, Yawen AU - Wang Y AUID- ORCID: 0009-0007-2667-0941 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Ma, Dengrong AU - Ma D AUID- ORCID: 0009-0004-1439-9611 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Han, Mei AU - Han M AUID- ORCID: 0009-0004-7185-158X AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Zan, Xiaohui AU - Zan X AUID- ORCID: 0009-0008-8475-6417 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Guo, Xinyuan AU - Guo X AUID- ORCID: 0009-0002-2050-6028 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. FAU - Liu, Jingfang AU - Liu J AUID- ORCID: 0000-0003-1908-4454 AD - The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. AD - Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China. LA - eng PT - Journal Article DEP - 20240325 PL - England TA - Postgrad Med JT - Postgraduate medicine JID - 0401147 SB - IM OTO - NOTNLM OT - 25-hydroxyvitamin D OT - Type 2 diabetes mellitus OT - bone turnover markers OT - non-alcoholic fatty liver disease OT - serum ferritin EDAT- 2024/03/21 12:43 MHDA- 2024/03/21 12:43 CRDT- 2024/03/21 06:33 PHST- 2024/03/21 12:43 [pubmed] PHST- 2024/03/21 12:43 [medline] PHST- 2024/03/21 06:33 [entrez] AID - 10.1080/00325481.2024.2333718 [doi] PST - aheadofprint SO - Postgrad Med. 2024 Mar 25:1-10. doi: 10.1080/00325481.2024.2333718.